查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1742833

全球急性腎損傷治療市場

Acute Kidney Injury Treatment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 366 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球急性腎損傷治療市場規模將達到 25 億美元

全球急性腎損傷治療市場規模預計在2024年達到18億美元，預計在2024-2030年的分析期內將以5.9%的複合年成長率成長，到2030年將達到25億美元。腎前性急性腎損傷治療是本報告分析的細分市場之一，預計其複合年成長率為5.2%，到分析期結束時規模將達到14億美元。腎內性急性腎損傷治療細分市場在分析期間的複合年成長率預計為6.7%。

美國市場規模估計為 4.784 億美元，而中國市場預計複合年成長率為 9.2%

美國急性腎損傷治療市場規模預計2024年達到4.784億美元。作為世界第二大經濟體，中國預計在2030年市場規模將達到4.995億美元，在分析期間（2024-2030年）的複合年成長率為9.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為3.0%和5.8%。在歐洲，預計德國的複合年成長率為3.8%。

全球急性腎損傷 (AKI) 治療市場 - 主要趨勢和促進因素摘要

為什麼急性腎衰竭成為多重系統護理和重症患者監護的重要焦點？

急性腎損傷 (AKI) 是指腎功能突然且通常可逆性的衰竭，它日益被認為是住院和重症患者的嚴重併發症。 AKI 通常由敗血症、脫水、藥物中毒或缺血誘發，並伴隨高發病率、高死亡率和延長住院時間。 AKI 的發生率不斷上升，尤其是在老齡化人口和加護治療環境中，這推動了對及時診斷、支持性干預和專業治療策略的需求。

由於 AKI 通常是慢性腎臟病(CKD) 和多重器官衰竭的前兆，因此早期發現和早期療育對於保護腎功能和提高生存率至關重要，這使得 AKI 治療成為腎臟病學、急診醫學和重症監護綜合護理途徑的關鍵組成部分。

治療方法和腎臟支持技術如何發展以實現有效的 AKI 管理？

目前的治療模式著重於支持性治療，包括穩定血流動力學、維持體液和電解質平衡以及停用腎毒性藥物。腎臟替代療法 (RRT)——間歇性血液透析機、連續性腎臟替代療法 (CRRT) 和腹膜透析——用於重症和難治性病例。 CRRT 因其較溫和的液體管理及血流動力學相容性，尤其在 ICU 中備受青睞。

藥物研究正在探索旨在減輕缺血性損傷、發炎和氧化壓力的腎臟保護藥物。 NGAL、KIM-1和Cystatin C等診斷性生物標記正被納入風險分層方案，從而實現更早的治療性介入。透析設備、生物相容性膜和自動化液體管理系統的創新，進一步提高了急性腎損傷（AKI）治療的精確度和病人安全性。

病患小組和醫療保健環境正在推動對 AKI 治療的需求？

AKI 常見於老年患者、ICU 患者、敗血症患者以及接受大型手術或顯影劑顯影劑的患者。由於暴露於腎毒性治療方案，AKI 在腫瘤科、心臟科和移植醫學領域也較為常見。醫院和加護病房是 AKI 的主要治療場所，其次是腎臟病診所和急性復健中心，用於追蹤和腎功能監測。

北美和歐洲佔據相當大的市場佔有率，這得益於先進的醫院基礎設施、高度的認知度以及完善的重症加護體系。亞太地區由於人口結構變化、ICU容量增加以及抗生素濫用和感染疾病負擔等風險因素的增加，AKI發生率正在上升。新興國家正透過培訓臨床醫生和採購設備等方式逐步投入AKI應對措施。

政策舉措、技術整合和風險管理如何影響市場擴張？

醫療機構正透過臨床指引、風險評估通訊協定和醫院警報系統，優先進行急性腎損傷 (AKI) 的預防和早期療育。 KDIGO 等組織正在進行標準化工作，推廣液體管理、藥物監測和腎臟輔助性治療的最佳實踐，而整合 EHR 的 AKI 警報系統則有助於即時檢測和臨床決策。

基於價值的護理模式和捆綁支付系統正在推動對早期急性腎損傷 (AKI)篩檢和避免透析的投資。醫院擴大採用數位化工具進行腎功能監測，研發機構也正在與產業界合作，加速生物標記和候選藥物的開發。這些多學科合作正在提高臨床對 AKI 的認知，並促進腎臟護理服務的系統性改進。

哪些因素將推動 AKI 治療市場的成長？

由於高風險族群發病率上升、重症加護能力提升以及腎臟支持技術的應用日益普及，AKI 治療市場正在蓬勃發展。關鍵促進因素包括臨床緊迫性、治療指南的不斷演變、CRRT 平台的創新以及診斷技術與急性護理工作流程的深度整合。隨著醫療保健系統將維護多種疾病患者的腎功能置於優先地位，AKI 治療正逐漸成為醫院護理的核心組成部分。

展望未來，市場動能將取決於相關人員如何有效地擴大早期檢測、制定干涉措施並遏制慢性腎臟併發症的進展。隨著腎臟健康成為多重器官疾病管理的核心，急性腎損傷治療很可能成為改變加護治療和預防護理途徑結果的策略槓桿。

部分

類型（腎前性、原發性、腎後性）、治療（治療方法、藥物）、分銷管道（醫院藥房、零售藥房、網路藥房）

受訪公司範例（值得關注的36家公司）

  • AbbVie Inc.
  • Amanta Healthcare
  • Amgen Inc.
  • AM-Pharma BV
  • Angion Biomedica Corp.
  • Arch Biopartners Inc.
  • Asahi Kasei Medical Co., Ltd.
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bristol-Myers Squibb Company
  • CalciMedica, Inc.
  • Eli Lilly and Company
  • Fresenius Medical Care AG & Co. KGaA
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Guard Therapeutics AB
  • ICU Medical, Inc.
  • Kringle Pharma, Inc.
  • LG Chem Ltd.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP34543

Global Acute Kidney Injury Treatment Market to Reach US$2.5 Billion by 2030

The global market for Acute Kidney Injury Treatment estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Prerenal Acute Kidney Injury Treatment, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Intrinsic Renal Acute Kidney Injury Treatment segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$478.4 Million While China is Forecast to Grow at 9.2% CAGR

The Acute Kidney Injury Treatment market in the U.S. is estimated at US$478.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$499.5 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Acute Kidney Injury (AKI) Treatment Market - Key Trends & Drivers Summarized

Why Is Acute Kidney Injury Emerging as a Critical Focus in Multisystem Care and Critical Illness Management?

Acute Kidney Injury (AKI)-a sudden and often reversible decline in renal function-is increasingly recognized as a serious complication in hospitalized and critically ill patients. Commonly triggered by sepsis, dehydration, drug toxicity, or ischemia, AKI is associated with high morbidity, mortality, and extended hospital stays. Its growing prevalence, particularly in aging populations and intensive care settings, is driving demand for timely diagnosis, supportive interventions, and specialized treatment strategies.

With AKI often serving as a precursor to chronic kidney disease (CKD) or multi-organ failure, early recognition and intervention have become central to preserving renal function and improving survival rates. This has made AKI treatment an essential component of integrated care pathways in nephrology, emergency medicine, and critical care.

How Are Therapeutic Approaches and Renal Support Technologies Evolving for Effective AKI Management?

Current treatment paradigms focus on supportive care, including hemodynamic stabilization, fluid and electrolyte balance, and withdrawal of nephrotoxic agents. Renal replacement therapy (RRT)-through intermittent hemodialysis, continuous renal replacement therapy (CRRT), or peritoneal dialysis-is used in severe or refractory cases. CRRT, in particular, is gaining traction in ICU settings due to its gentler fluid management and hemodynamic compatibility.

Pharmaceutical research is exploring renoprotective agents aimed at mitigating ischemic damage, inflammation, and oxidative stress. Biomarker-driven diagnostics-such as NGAL, KIM-1, and cystatin C-are being incorporated into risk stratification protocols, enabling earlier therapeutic intervention. Innovations in dialysis machines, biocompatible membranes, and automated fluid management systems are further enhancing treatment precision and patient safety in AKI care.

Which Patient Groups and Healthcare Settings Are Driving AKI Treatment Demand?

AKI frequently affects elderly individuals, ICU patients, individuals with sepsis, and those undergoing major surgery or receiving contrast agents. It is also prevalent in oncology, cardiology, and transplant care due to exposure to nephrotoxic regimens. Hospitals and intensive care units are the primary treatment environments, followed by nephrology clinics and post-acute rehabilitation centers for follow-up and renal function monitoring.

North America and Europe account for significant market share, supported by advanced hospital infrastructure, high awareness, and comprehensive critical care frameworks. Asia-Pacific is witnessing increasing incidence due to demographic transitions, growing ICU capacity, and rising exposure to risk factors such as antibiotic overuse and infectious disease burden. Emerging economies are gradually investing in AKI preparedness through clinician training and equipment procurement.

How Are Policy Initiatives, Technological Integration, and Risk Management Practices Shaping Market Expansion?

Health authorities are prioritizing AKI prevention and early intervention through clinical guidelines, risk assessment protocols, and hospital-based alert systems. Standardization efforts from bodies such as KDIGO (Kidney Disease: Improving Global Outcomes) are promoting best practices in fluid management, drug monitoring, and renal support therapy. Meanwhile, EHR-integrated AKI alert systems are aiding real-time detection and clinical decision-making.

Value-based care models and bundled payment systems are driving investments in early AKI screening and avoidance of dialysis initiation. Hospitals are increasingly adopting digital tools for kidney function surveillance, while research institutions are collaborating with industry to accelerate biomarker development and novel drug candidates. These cross-sector efforts are raising the clinical profile of AKI and catalyzing systemic improvements in renal care delivery.

What Are the Factors Driving Growth in the AKI Treatment Market?

The AKI treatment market is growing in response to rising incidence in high-risk populations, expanding critical care capacity, and increasing adoption of renal support technologies. Key drivers include clinical urgency, evolving treatment guidelines, innovation in CRRT platforms, and deeper integration of diagnostics into acute care workflows. As health systems prioritize kidney function preservation across a range of conditions, AKI treatment is becoming a core focus of hospital-based care.

Looking ahead, market momentum will depend on how effectively stakeholders can scale early detection, tailor interventions, and reduce progression to chronic kidney complications. As kidney health becomes central to managing multisystem diseases, could acute kidney injury treatment emerge as a strategic lever in transforming outcomes across intensive and preventive care pathways?

SCOPE OF STUDY:

The report analyzes the Acute Kidney Injury Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury); Treatment (Therapy, Drugs); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AbbVie Inc.
  • Amanta Healthcare
  • Amgen Inc.
  • AM-Pharma B.V.
  • Angion Biomedica Corp.
  • Arch Biopartners Inc.
  • Asahi Kasei Medical Co., Ltd.
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bristol-Myers Squibb Company
  • CalciMedica, Inc.
  • Eli Lilly and Company
  • Fresenius Medical Care AG & Co. KGaA
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Guard Therapeutics AB
  • ICU Medical, Inc.
  • Kringle Pharma, Inc.
  • LG Chem Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Acute Kidney Injury Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Hospitalization Rates for Critical Illnesses Throw the Spotlight on Acute Kidney Injury (AKI) Treatment Needs
    • Increasing Incidence of Sepsis and Cardiovascular Complications Spurs AKI Diagnosis and Intervention Demand
    • Advancements in Renal Biomarkers Strengthen the Business Case for Early AKI Detection and Treatment
    • Growing Use of Continuous Renal Replacement Therapy (CRRT) Drives Equipment and Consumable Adoption
    • Integration of AI-Based Predictive Tools in ICU Settings Bodes Well for Early AKI Risk Assessment
    • Rising Availability of Portable Dialysis Machines Expands Access to AKI Management in Non-Traditional Settings
    • Higher Adoption of EHR and Data Analytics Enhances AKI Monitoring and Decision-Making in Critical Care
    • Growth in Pediatric and Geriatric AKI Cases Sets the Stage for Demographic-Specific Treatment Protocols
    • Emergence of Biocompatible Dialysis Filters Enhances Patient Safety and Therapy Tolerance in AKI Treatment
    • Rising Focus on Post-AKI Recovery and Long-Term Kidney Function Preservation Drives Innovation in Follow-Up Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Acute Kidney Injury Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Acute Kidney Injury Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Prerenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Prerenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Prerenal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intrinsic Renal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intrinsic Renal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intrinsic Renal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Postrenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Postrenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Postrenal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • JAPAN
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CHINA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • EUROPE
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Acute Kidney Injury Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • FRANCE
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • GERMANY
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • INDIA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Acute Kidney Injury Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Acute Kidney Injury Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AFRICA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030

IV. COMPETITION